Health Care & Life Sciences » Pharmaceuticals | Harbin Pharmaceutical Group Co. Ltd.

Harbin Pharmaceutical Group Co. Ltd. A | Cash Flow

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
137
198
614
844
464
404
Depreciation, Depletion & Amortization
443
457
484
476
448
430
Other Funds
8
18
7
128
48
41
Funds from Operations
786
828
1,315
1,405
919
886
Changes in Working Capital
642
308
346
1,373
769
193
Net Operating Cash Flow
143
1,136
1,660
2,778
150
694
Capital Expenditures
370
375
291
107
102
Sale of Fixed Assets & Businesses
7
2
6
33
4
Purchase/Sale of Investments
150
-
-
-
30
Net Investing Cash Flow
299
385
285
77
68
Cash Dividends Paid - Total
-
127
1,917
-
1,271
Issuance/Reduction of Debt, Net
139
9
34
14
-
Net Financing Cash Flow
147
153
1,891
114
1,207
Net Change in Cash
303
598
515
2,816
1,125
Free Cash Flow
226
761
1,369
2,671
48
Deferred Taxes & Investment Tax Credit
24
25
13
25
9
12
Other Uses
87
11
-
2
-

About Harbin Pharmaceutical Group Co.

View Profile
Address
No. 7 Qunli Avenue
Harbin Heilongjiang 150070
China
Employees -
Website http://www.hayao.com
Updated 07/08/2019
Harbin Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, wholesale, and retail of pharmaceutical products. It pharmaceutical covers chemical raw materials, chemical agents, biological agents, Chinese medicine, and health care products. It specializes in anti-infection, cardiovascular and cerebrovascular, cold medicine, digestive system, anti-tumor drugs, and nutritional supplements.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.